Hyperproliferation of keratinocytes, hyperkeratosis, inflammatory cell infiltration and hypervascularity were histologically suppressed by topical imatinib mesylate. The expression of angiogenic factors including fibroblast growth factor and vascular endothelial growth factor was decreased.
[Experimental Dermatology]